Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12226
CALL
Gorman-Rupp
GRC
$2.13B
| $52.6K | ﹤0.01% |
1,500
| – | – |
|
|
SY
12227
CALL
So-Young International
SY
$225M
| $52.6K | ﹤0.01% |
+59,400
| New | +$54.5K |
|
12228
Femasys
FEMY
$6.91M
| $52.5K | ﹤0.01% |
2,101
+53
| +3% | +$1.43K |
|
|
IBO
12229
Impact BioMedical
IBO
$49.5M
| $52.5K | ﹤0.01% |
+60,315
| New | +$104K |
|
12230
CALL
AbCellera Biologics
ABCL
$3.49B
| $52.4K | ﹤0.01% |
23,500
-99,300
| -81% | -$285K |
|
12231
PUT
ProShares Ultra Real Estate
URE
$60.3M
| $52.3K | ﹤0.01% |
800
-1,200
| -60% | -$77.9K |
|
|
TBRG
12232
PUT
DELISTED
TruBridge
TBRG
| $52.3K | ﹤0.01% |
+1,900
| New | +$49.5K |
|
12233
PUT
Bioventus
BVS
$1.2B
| $52.2K | ﹤0.01% |
5,700
-15,300
| -73% | -$153K |
|
12234
PUT
Cushman & Wakefield Ltd
CWK
$3.38B
| $52.1K | ﹤0.01% |
5,100
-7,800
| -60% | -$94.8K |
|
|
KW
12235
CALL
DELISTED
Kennedy-Wilson Holdings
KW
| $52.1K | ﹤0.01% |
6,000
+4,600
| +329% | +$41.9K |
|
12236
CALL
Alta Equipment Group
ALTG
$237M
| $52.1K | ﹤0.01% |
11,100
-18,500
| -63% | -$115K |
|
12237
CALL
Virco
VIRC
$95.2M
| $52K | ﹤0.01% |
5,500
-20,300
| -79% | -$211K |
|
12238
PUT
SI-BONE Inc
SIBN
$848M
| $51.9K | ﹤0.01% |
3,700
+600
| +19% | +$9.68K |
|
12239
CALL
Garrett Motion
GTX
$5.41B
| $51.9K | ﹤0.01% |
6,200
-5,700
| -48% | -$52.9K |
|
|
BGFV
12240
DELISTED
Big 5 Sporting Goods
BGFV
| $51.7K | ﹤0.01% |
53,481
+28,097
| +111% | +$38.5K |
|
12241
PUT
AerSale
ASLE
$280M
| $51.7K | ﹤0.01% |
6,900
-16,000
| -70% | -$114K |
|
12242
CALL
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$549M
| $51.7K | ﹤0.01% |
700
+500
| +250% | +$39.7K |
|
12243
CALL
Spyre Therapeutics
SYRE
$9.14B
| $51.6K | ﹤0.01% |
3,200
-3,700
| -54% | -$77K |
|
12244
PUT
Alto Neuroscience
ANRO
$1.26B
| $51.6K | ﹤0.01% |
23,900
+7,600
| +47% | +$27.2K |
|
12245
CALL
MarineMax
HZO
$1.15B
| $51.6K | ﹤0.01% |
2,400
+200
| +9% | +$5.34K |
|
12246
CALL
ARK Space & Defense Innovation ETF
ARKX
$865M
| $51.4K | ﹤0.01% |
2,900
-23,500
| -89% | -$464K |
|
12247
PUT
Kopin
KOPN
$1.02B
| $51.4K | ﹤0.01% |
55,100
+10,300
| +23% | +$15.1K |
|
12248
CALL
Helios Technologies
HLIO
$2.69B
| $51.3K | ﹤0.01% |
1,600
-5,300
| -77% | -$214K |
|
12249
CALL
Pliant Therapeutics
PLRX
$66.3M
| $51.3K | ﹤0.01% |
38,000
+21,100
| +125% | +$128K |
|
|
BHR
12250
CALL
Braemar Hotels & Resorts
BHR
$139M
| $51.3K | ﹤0.01% |
20,600
-10,100
| -33% | -$27.6K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.